-
1
Fexuprazan safeguards the esophagus from hydrochloric acid-induced damage by suppressing NLRP1/Caspase-1/GSDMD pyroptotic pathway
Published 2024-12-01Subjects: Get full text
Article -
2
-
3
Potassium-competitive acid blockers, a new therapeutic class, and their role in acid-related diseases: a narrative review
Published 2022-08-01Subjects: Get full text
Article -
4
-
5
Comparison of hepatotoxicity of tegoprazan, a novel potassium-competitive acid blocker, with proton pump inhibitors using real-world data: A nationwide cohort study
Published 2023-01-01Subjects: “…P-CAB…”
Get full text
Article -
6
Novel Cocrystals of Vonoprazan: Machine Learning-Assisted Discovery
Published 2022-02-01Subjects: Get full text
Article -
7
Simultaneous Determination of Multiple Acid-Suppressing Drugs by UPLC-MS/MS Method and Application for Pharmacokinetics Study
Published 2025-02-01Subjects: Get full text
Article -
8
Vonoprazan a novel potassium competitive acid blocker; another leap forward
Published 2024-05-01Subjects: “…potassium-competitive acid blocker (p-cab)…”
Get full text
Article -
9
In Vitro Metabolism and Transport Characteristics of Zastaprazan
Published 2024-06-01Subjects: “…potassium-competitive acid blocker (P-CAB)…”
Get full text
Article